BioNxt Solutions, Inc. engages in the business of producing, extracting, and selling medical cannabis. It focuses on the strategic assets and investments in the field of rapid pathogen screening systems and next generation drug delivery. The company was founded by Hugh A. D. Rogers, Wolfgang Probst and Raimar Löbenberg on December 12, 2017 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BioNxt Solutions Inc market cap is $22.75M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. BioNxt Solutions Inc 52 week high is $0.506 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BioNxt Solutions Inc 52 week low is $0.1001 as of November 18, 2026.
BioNxt Solutions Inc stock price today is $0.1672.
BioNxt Solutions Inc stock price yesterday was $0.1868.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. BioNxt Solutions Inc's P/E ratio is -4.39.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. BioNxt Solutions Inc P/B ratio is -5.1621.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. BioNxt Solutions Inc 50-day moving average is $0.227.